Premium
Acute cerebellar dysfunction with high‐dose ARA‐C therapy
Author(s) -
Salinsky M. C.,
Levine R. L.,
Aubuchon J. P.,
Schutta H. S.
Publication year - 1983
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19830201)51:3<426::aid-cncr2820510312>3.0.co;2-s
Subject(s) - medicine , toxicity , refractory (planetary science) , dentate nucleus , cytarabine , regimen , cerebellum , gastroenterology , oncology , chemotherapy , physics , astrobiology
The authors report a patient with clinical and morphologic evidence of acute cerebellar toxicity after receiving high‐dose cytosine arabinoside (ARA‐C) (3000 mg/m 2 /12 hours) for refractory AML. Damage of Purkinje cells and dentate nucleus was demonstrated. Reversible cerebellar toxicity has previously been noted in patients on an identical regimen. Signs of cerebellar dysfunction mandate immediate cessation of highdose ARA‐C therapy.